• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Lantern Pharma(LTRN.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Nov13
Lantern Pharma Reports Q3 2025 Net Loss of $4.2 Million
15:26
Nov12
Lantern Pharma released FY2025 9 Months Earnings on November 12 Pre-Market (EST), with actual revenue of USD 0 and EPS of USD -1.2078
14:30
Lantern Pharma released FY2025 Q3 earnings on November 12 Pre-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3856 (forecast USD -0.47)
14:30
Nov6
Lantern Pharma to Release FY2025 Q3 Earnings on November 13, Pre-Market EST, Forecast EPS -0.47 USD
00:09
Nov3
Lantern Pharma Displays AI-Based Cancer Drug Development Pipeline
18:15
Oct30
Lantern Pharma Inc. Makes Breakthrough in Oncology Drug Development with AI Platform RADR®
15:43

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -4.177 M, EPS -0.3856

Aug13
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -4.331 M, EPS -0.4015

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -4.537 M, EPS -0.4206

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
9.530
+132.44%
+5.430
ANGH
3.770
+62.50%
+1.450
WTO
1.020
+61.09%
+0.387
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2731
+40.77%
+0.079
FGMCR
0.5500
+33.50%
+0.138
ESHA
19.180
+33.38%
+4.800
IPEXR
0.8000
+31.97%
+0.194
RDACR
0.2400
+26.32%
+0.050
DVLT
0.6521
+26.25%
+0.136
View More